HSA — authorised 4 December 1997
- Marketing authorisation holder: PALADIN LABS
- Status: likely_approved
HSA authorised Antizol on 4 December 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 4 December 1997.
PALADIN LABS holds the Singaporean marketing authorisation.